# High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

Study · id `cardio:ct-nct07059689` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07059689](<https://clinicaltrials.gov/study/NCT07059689>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07059689

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 114 participants.

## Technical summary

Registry record NCT07059689. Randomized; no masking; primary purpose treatment. Start 2025-06-05 (actual); primary completion 2025-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 114 participants (planned count; ClinicalTrials.gov record NCT07059689, source copy `cardio:ctgov-nct07059689-2025-07-11`, retrieved 2026-10-26)
- Started: 2025-06-05 (actual) (ClinicalTrials.gov record NCT07059689, source copy `cardio:ctgov-nct07059689-2025-07-11`, retrieved 2026-10-26)
- Primary completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT07059689, source copy `cardio:ctgov-nct07059689-2025-07-11`, retrieved 2026-10-26)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT07059689, source copy `cardio:ctgov-nct07059689-2025-07-11`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT07059689, source copy `cardio:ctgov-nct07059689-2025-07-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07059689-2025-07-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery
- Condition: Heart Defects, Congenital
- Condition: Intensive Care Units, Pediatric
- Condition: Respiration, Artificial
- Condition: Extubation
- Intervention (Device): High Flow Nasal Cannula (HFNC)
- Intervention (Device): Non-Invasive Ventilation (NIV)
- Lead sponsor: Universitas Indonesia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Universitas Indonesia (`cardio:org-universitas-indonesia`)

## Provenance

Content hash: acdad6ae6ab8c264fef2891445c6727ed7bc2675e3d8cc3586dc039618dbc359
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
